Standardisation and licensing of combination vaccines based on DTP.
Development of combination vaccines is a time consuming and expensive exercise with significant technical, clinical, regulatory, manufacturing and marketing challenges, which is likely to result in a rationalisation of production worldwide.
Gust
I
I
Research and Development Director, CSL Limited, Melbourne, Australia.
D001688:Biological Products / Q000592:standards*; D015721:Diphtheria-Tetanus-Pertussis Vaccine / Q000592:standards*; D005544:Forecasting; D006801:Humans; D008004:Licensure; D014611:Vaccination / Q000331:legislation & jurisprudence / Q000592:standards / Q000639:trends; D014944:World Health Organization
D001688:Biological Products; D015721:Diphtheria-Tetanus-Pertussis Vaccine